3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma
68
Lymphoma, Non-Hodgkin
53
Lymphoma, Large B-Cell, Diffuse
47
Hodgkin Disease
42
Precursor Cell Lymphoblastic Leukemia-Lymphoma
41
Leukemia, Myeloid, Acute
41
Small Cell Lung Carcinoma
37
Leukemia
37
Burkitt Lymphoma
32
Lymphoma, Mantle-Cell
29
Lymphoma, Follicular
28
Lung Neoplasms
20
Carcinoma, Non-Small-Cell Lung
20
Multiple Myeloma
19
Congenital Abnormalities
18
Lymphoma, Large-Cell, Immunoblastic
17
Lymphoma, Large-Cell, Anaplastic
17
Recurrence
15
Lymphoma, B-Cell, Marginal Zone
15
Lymphoma, B-Cell
15
Leukemia, Lymphocytic, Chronic, B-Cell
15
Neuroblastoma
13
Neoplasms
13
Myelodysplastic Syndromes
11
Waldenstrom Macroglobulinemia
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
10
Lymphoma, T-Cell
10
Immunoblastic Lymphadenopathy
10
Sarcoma
9
Myeloproliferative Disorders
9
Interventions
vandetanib
7
Sorafenib
6
Magnetic Resonance Spectroscopy
6
lenvatinib
5
cabozantinib
5
Sunitinib
4
Iodine-131
4
selpercatinib
3
AZD 6244
3
trametinib
2
tipifarnib
2
durvalumab
2
dabrafenib
2
alectinib
2
Triiodothyronine
2
Thyroxine
2
Thyrotropin Alfa
2
Paclitaxel
2
Nivolumab
2
Ipilimumab
2
Fluorodeoxyglucose F18
2
Everolimus
2
Bortezomib
2
Axitinib
2
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
2
tremelimumab
1
temsirolimus
1
tanespimycin
1
sapanisertib
1
romidepsin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Thyroid Neoplasms
×
Etoposide
×
Clear all
No trials found.